A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica
Clinical Trial Grant
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
September 1, 2015
End Date
October 9, 2017
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
September 1, 2015
End Date
October 9, 2017